Bdnf augmentation using riluzole reverses doxorubicin-induced decline in cognitive function and neurogenesis

HIGHLIGHTS

• who: Manal T. Usmani from the Department of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, CA, USA have published the research work: BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis, in the Journal: (JOURNAL)
• what: This study provided pre-clinical evidence that RZ reverses chemotherapy-induced cognitive decline in a mouse model.
• how: For this pre-clinical study the authors used adult female mice. The statistical analyses of cognitive function biochemical and immunohistochemical data were conducted using a two-way ANOVA (GraphPad Prism v8.0 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.